Search Result "ANSD family."
An OTOF Frameshift Variant Associated with Auditory Neuropathy Spectrum Disorder
Journal: Current Genomics
Volume: 19 Issue: 5 Year: 2018 Page: 370-374
Author(s): Hong Xia,Xiangjun Huang,Hongbo Xu,Yi Guo,Pengzhi Hu,Xiong Deng,Zhijian Yang,An Liu,Hao Deng
The Families of Kinases Removing the Ca2+ Releasing Second Messenger Ins(1,4,5)P3
Journal: Current Molecular Medicine
Volume: 4 Issue: 3 Year: 2004 Page: 277-290
Author(s): Marcus M. Nalaskowski, Georg W. Mayr
Privileged Structures as Leads in Medicinal Chemistry
Journal: Current Medicinal Chemistry
Volume: 13 Issue: 1 Year: 2006 Page: 65-85
Author(s): Luca Costantino, Daniela Barlocco
Identification and Characterization of Sir2 Inhibitors Through Phenotypic Assays in Yeast
Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 7 Issue: 7 Year: 2004 Page: 661-668
Author(s): Jeff Posakony, Maki Hirao, Antonio Bedalov
Death Receptor Activation-Induced Hepatocyte Apoptosis and Liver Injury
Journal: Current Molecular Medicine
Volume: 3 Issue: 6 Year: 2003 Page: 491-508
Author(s): Xiao-Ming Yin, Wen-Xing Ding
New Developments and Applications of Docking and High-Throughput Docking for Drug Design and in silico Screening
Journal: Current Computer-Aided Drug Design
Volume: 2 Issue: 1 Year: 2006 Page: 83-91
Author(s): Philippe Ferrara, John P. Priestle, Eric Vangrevelinghe, Edgar Jacoby
Tachykinins and Tachykinin Receptors: Structure and Activity Relationships
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2004 Page: 2045-2081
Author(s):
Preface [Hot Topic: Exogenous Factors Affecting Cardiovascular and Hematological Targets (Guest Editor: R. Manjunatha Kini)]
Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 4 Issue: 4 Year: 2004 Page: ii-ii
Author(s): R. Manjunatha Kini
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Journal: Current Cancer Drug Targets
Volume: 5 Issue: 5 Year: 2005 Page: 325-344
Author(s): Marina A. Dobrovolskaia, Serguei V. Kozlov
Development of Vascular Endothelial Growth Factor Receptor (VEGFR) Kinase Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 6 Year: 2004 Page: 731-745
Author(s): T. L. Underiner, B. Ruggeri, D. E. Gingrich